What is the revenue growth target for FY27?

Management expects revenue to grow by 25% to 30% in FY27, a sharp increase from the 6% growth recorded in FY26.

How much does the company plan to spend on expansion?

The company has earmarked ₹20-25 crore for capital expenditure, which includes the development of a new diagnostic center in Dwarka.

What is the expected revenue from the new Dwarka center?

The new center in Dwarka is expected to generate between ₹5 crore and ₹6 crore in annual revenue.

What is the current debt position of the company?

Star Imaging is net cash positive with a balance of ₹31 crore as of March 2026 and intends to remain largely debt-free.

Are current EBITDA margins sustainable?

Management maintains that the current EBITDA margins of 37.5% are sustainable.

Earnings · Hospital & Healthcare · Micro cap

Star Imaging targets 25-30% revenue growth in FY27

The diagnostic chain plans to deploy ₹20-25 crore in capex while maintaining a net cash position of ₹31 crore.

— 1 earlier story on Star Imaging and Path Lab Ltd. →

STARIMAGIN 27 May 2026 · 4:56 PM IST Verify on BSE · NSE

Mkt cap₹126 cr

P/E7.94×

ROE33.78%

Debt / eq.0.69

25% to 30% Management's revenue growth guidance for FY27.

What's new

Management targets 25-30% revenue growth for FY27 after a 6% increase in FY26.
Capex of ₹20-25 crore is planned, including a new Dwarka facility.
The company ended FY26 with a net cash position of ₹31 crore.

Why this matters

Star Imaging is attempting to accelerate growth significantly after a modest 6% showing in FY26. Maintaining 37.5% EBITDA margins while funding expansion from a net cash position of ₹31 crore is the central test for this nano-cap provider.

What we're watching

Revenue contribution from the new Dwarka center.
Whether the company maintains its debt-free status during the capex cycle.
Actual FY27 growth against the 25-30% target.

The full read

Star Imaging and Path Lab reported 6% revenue growth to ₹88.5 crore in FY26. Looking ahead, management targets a significant acceleration to 25% to 30% growth in FY27. To support this, the company plans ₹20-25 crore in capital expenditure, including a new diagnostic center in Dwarka that is expected to add ₹5-6 crore in annual revenue. The company is currently net cash positive at ₹31 crore and aims to remain debt-free while sustaining 37.5% EBITDA margins. While the transcript confirms no major surprises, it provides the necessary context for investors to adjust their models. The next test is whether the company can successfully scale its operations to meet these ambitious growth targets without eroding its current margin profile or exhausting its cash reserves.

Questions answered

What is the revenue growth target for FY27?: Management expects revenue to grow by 25% to 30% in FY27, a sharp increase from the 6% growth recorded in FY26.
How much does the company plan to spend on expansion?: The company has earmarked ₹20-25 crore for capital expenditure, which includes the development of a new diagnostic center in Dwarka.
What is the expected revenue from the new Dwarka center?: The new center in Dwarka is expected to generate between ₹5 crore and ₹6 crore in annual revenue.
What is the current debt position of the company?: Star Imaging is net cash positive with a balance of ₹31 crore as of March 2026 and intends to remain largely debt-free.
Are current EBITDA margins sustainable?: Management maintains that the current EBITDA margins of 37.5% are sustainable.

Mentioned: Star Imaging and Path Lab Ltd. · Dwarka facility · FY26

Primary source BSE · NSE · Tijori

An independent reading of the company's own disclosure — the primary filing above is the final word.

Story so far

All notes on STARIMAGIN →

27 May 2026 · 4:56 PM IST Star Imaging targets 25-30% revenue growth in FY27
5d ago Star Imaging reports stagnant FY26 revenue of ₹5,002 lakhs